Moffitt logo

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Learn More

Clinical Trials Search

Clinical Trial 21108

Cancer Type: Thoracic
Study Type: Prevention
NCT#:

Phase: N/A
Prinicipal Investigator: Vani Simmons

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Motivating Smoking Cessation and Relapse Prevention among Lung Cancer Patients: Helping and Empowering pAtients for Living a life Smoke-free (Project HEALS)

Summary

The purpose of the study is to gather information that will be used to adapt a smoking cessation intervention for lung cancer patients

Objective

Primary Aim: Examine feasibility outcomes of interest including study eligibility, ability to recruit and retain participants in the study, intervention delivery rates, and participant satisfaction with the UC+MAPS+RP treatment. Exploratory Aim: Estimate the efficacy of UC+MAPS+RP compared to UC in facilitating abstinence from smoking toward development of a full-scale RCT.

Treatments

Therapies

Medications

Inclusion Criteria

  • Age >18
  • Smoked at least 100 cigarettes in their lifetime
  • Current smoking (defined as self-report of any smoking, even a puff, in the past 30 days)
  • Diagnosis of lung cancer
  • Able to read/write English
  • Not currently enrolled in a smoking cessation program
  • Have a working phone
  • Valid home address

  • Exclusion Criteria

  • Current use of tobacco cessation medications
  • Another household member enrolled in the study
  • Contraindication of nicotine patch use unless under the supervision of a physician as advised by project staff
  • Moffitt clinical trial participant at time of enrollment
  • Diagnosed with distant metastases

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

    ;